Evidence map›Paper›PMID 37567908›Full record

ArticleScientific reports2023

Integrative genetic and genomic networks identify microRNA associated with COPD and ILD.

Ana B Pavel, Carly Garrison, Lingqi Luo, Gang Liu, Daniel Taub, Ji Xiao, Brenda Juan-Guardela, John Tedrow, Yuriy O Alekseyev, Ivana V Yang and 8 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Participation of miRNA-23a-3p in Pulmonary Tuberculosis Through Macrophages via the JAK-STAT Pathway.International journal of chronic obstructive pulmonary disease · 2026
    Article
  5. Article
  6. Article
  7. Optimizing miRNA transfection for screening in precision cut lung slices.American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Ana B PavelDepartment of Medicine, Boston University School of Medicine, 72 East Concord St, Boston, MA, 02118, USA. anapavel@bu.edu.
Carly GarrisonDepartment of Medicine, Boston University School of Medicine, 72 East Concord St, Boston, MA, 02118, USA.
Lingqi LuoDepartment of Medicine, Boston University School of Medicine, 72 East Concord St, Boston, MA, 02118, USA.
Gang LiuDepartment of Medicine, Boston University School of Medicine, 72 East Concord St, Boston, MA, 02118, USA.
Daniel TaubDepartment of Medicine, Boston University School of Medicine, 72 East Concord St, Boston, MA, 02118, USA.
Ji XiaoDepartment of Medicine, Boston University School of Medicine, 72 East Concord St, Boston, MA, 02118, USA.
Brenda Juan-GuardelaDepartment of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
John TedrowDepartment of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Yuriy O AlekseyevDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, USA.
Ivana V YangDepartment of Medicine, University of Colorado, Aurora, CO, USA.
Mark W GeraciDepartment of Medicine, University of Colorado, Aurora, CO, USA.
Frank SciurbaDepartment of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
David A SchwartzDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, USA.
Naftali KaminskiDepartment of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Jennifer BeaneDepartment of Medicine, Boston University School of Medicine, 72 East Concord St, Boston, MA, 02118, USA.
Avrum SpiraDepartment of Medicine, Boston University School of Medicine, 72 East Concord St, Boston, MA, 02118, USA.
Marc E LenburgDepartment of Medicine, Boston University School of Medicine, 72 East Concord St, Boston, MA, 02118, USA.
Joshua D CampbellDepartment of Medicine, Boston University School of Medicine, 72 East Concord St, Boston, MA, 02118, USA. camp@bu.edu.
Boston University · USUniversity of Pittsburgh Medical Center · USNorman Regional Health System · USUniversity of Colorado Anschutz Medical Campus · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Targeting early events in MUC5B-driven lung injury and fibrosisP01HL162607 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI David Albert Schwartz · 2023 to 2026
$12.4M
Lung Genomics Research ConsortiumRC2HL101715 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI GERACI, MARK W, KAMINSKI, NAFTALI · 2009 to 2010
$11.4M
Preclinical Pulmonary Fibrosis, an opportune rare disease cohortUH3HL151865 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI SCHWARTZ, DAVID ALBERT · 2022 to 2025
$4.3M
Molecular Determinants of Usual Interstitial Pneumonia (UIP)R01HL158668 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI David Albert Schwartz, Ivana V Yang · 2022 to 2026
$3.5M
Integrative Omics to Discover Molecular Determinants of COPDR01HL118542 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HACKETT, TILLIE-LOUISE, LENBURG, MARC ELLIOTT · 2013 to 2016
$2.7M
BLRD VA I01 BX005295NCATS NIH HHS UL1 TR001863NHLBI NIH HHS P01 HL162607NHLBI NIH HHS R01 HL118542NHLBI NIH HHS R01 HL158668NHLBI NIH HHS RC2 HL101715NHLBI NIH HHS UH3 HL151865
6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) are clinically and molecularly heterogeneous diseases. We utilized clustering and integrative network analyses to elucidate roles for microRNAs (miRNAs) and miRNA isoforms (isomiRs) in COPD and ILD pathogenesis. Short RNA sequencing was performed on 351 lung tissue samples of COPD (n = 145), ILD (n = 144) and controls (n = 64). Five distinct subclusters of samples were identified including 1 COPD-predominant cluster and 2 ILD-predominant clusters which associated with different clinical measurements of disease severity. Utilizing 262 samples with gene expression and SNP microarrays, we built disease-specific genetic and expression networks to predict key miRNA regulators of gene expression. Members of miR-449/34 family, known to promote airway differentiation by repressing the Notch pathway, were among the top connected miRNAs in both COPD and ILD networks. Genes associated with miR-449/34 members in the disease networks were enriched among genes that increase in expression with airway differentiation at an air-liquid interface. A highly expressed isomiR containing a novel seed sequence was identified at the miR-34c-5p locus. 47% of the anticorrelated predicted targets for this isomiR were distinct from the canonical seed sequence for miR-34c-5p. Overexpression of the canonical miR-34c-5p and the miR-34c-5p isomiR with an alternative seed sequence down-regulated NOTCH1 and NOTCH4. However, only overexpression of the isomiR down-regulated genes involved in Ras signaling such as CRKL and GRB2. Overall, these findings elucidate molecular heterogeneity inherent across COPD and ILD patients and further suggest roles for miR-34c in regulating disease-associated gene-expression.

Indexed as

Lung Diseases, InterstitialMicroRNAsPulmonary Disease, Chronic ObstructiveGenomicsHumansLungMicroRNAs

Identifiers

PMID37567908
PMCPMC10421936
OpenAlexW4385761710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.